Skip to main content

Table 1 Percentage of ARGs co-occurring with MGEs before, during, and after antibiotic exposure

From: Oral administration of antibiotics increased the potential mobility of bacterial resistance genes in the gut of the fish Piaractus mesopotamicus

Day Phage integrases Transposon Transposase RteC Resolvase Total*
0 1.78 ± 0.69 0.00 ± 0.00 1.93 ± 0.53 0.20 ± 0.28 0.28 ± 0.39 4.19 ± 0.04
1 0.96 ± 0.47 0.00 ± 0.00 3.52 ± 1.00 0.00 ± 0.00 0.18 ± 0.26 4.66 ± 1.72
4 1.36 ± 0.33 0.63 ± 0.45 4.40 ± 0.83 0.19 ± 0.26 0.34 ± 0.47 6.91 ± 1.03
7 2.21 ± 0.84 1.53 ± 0.12 6.09 ± 0.31 0.00 ± 0.00 0.95 ± 0.48 10.78 ± 0.57
11 2.61 ± 2.61 0.00 ± 0.00 3.05 ± 3.05 0.00 ± 0.00 0.29 ± 0.29 5.95 ± 5.95
13 2.72 ± 1.63 0.00 ± 0.00 2.84 ± 0.83 0.41 ± 0.29 0.00 ± 0.00 5.96 ± 2.26
18 1.42 ± 0.56 0.00 ± 0.00 2.32 ± 0.76 0.00 ± 0.00 0.16 ± 0.23 3.91 ± 0.70
26 0.80 ± 0.57 0.00 ± 0.00 2.25 ± 2.09 0.19 ± 0.26 0.62 ± 0.47 3.87 ± 2.30
34 1.12 ± 1.59 0.00 ± 0.00 2.94 ± 2.52 0.00 ± 0.00 0.00 ± 0.00 4.07 ± 1.50
Control 0.93 ± 1.31 0.00 ± 0.00 0.82 ± 1.16 0.27 ± 0.38 0.40 ± 0.56 2.41 ± 1.29
  1. Days under antibiotic treatment are presented in italics. ± indicates the S.D. Control was sampled at day 34
  2. *Total includes ARGs co-occurring with more than one MGE